Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Yurek M. Paprocki"'
Publikováno v:
Diabetes. 71
Objectives: To evaluate health care resource utilization and cost in adults with type 2 diabetes mellitus (T2DM) and myocardial infarction (MI) . Methods: We conducted a retrospective cohort study using the Optum® Clinformatics® Data Mart claims da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55ef7d772b679ed81ad4d10a5917e10e
https://doi.org/10.2337/db22-891-p
https://doi.org/10.2337/db22-891-p
Publikováno v:
Diabetes. 71
Objectives: To evaluate health care resource utilization and all-cause healthcare costs in adults with type 2 diabetes mellitus (T2DM) and stroke. Methods: Patients ≥ 18 years of age with T2DM, with or without incident stroke, were identified betwe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38f5bd66e392426b78806fa3e7a91942
https://doi.org/10.2337/db22-890-p
https://doi.org/10.2337/db22-890-p
Publikováno v:
Diabetes. 71
Objectives: To evaluate health care utilization and cost in adults with type 2 diabetes mellitus (T2DM) and peripheral artery disease (PAD) . Methods: Patients ≥ 18 years of age with T2DM, with or without PAD, were identified between January 1, 201
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eddf97d9154a904f60b3a9343e07f49c
https://doi.org/10.2337/db22-903-p
https://doi.org/10.2337/db22-903-p
Autor:
Joshua Noone, Yurek M. Paprocki, Vincent J. Willey, Simo Du, Caroline Swift, Nitin Shivappa, Hiangkiat Tan
Publikováno v:
Diabetes. 70
Background: This study presents real-world evidence on effectiveness of sema OW in a broad cohort of US commercially insured and Medicare Advantage T2D patients. Methods: Claims and lab result data were used to identify T2D patients who initiated sem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b44330ce65c3af49a9a68e4b816a102
https://doi.org/10.2337/db21-652-p
https://doi.org/10.2337/db21-652-p
Autor:
Caroline Swift, Hiangkiat Tan, Yurek M. Paprocki, Vincent J. Willey, Joshua Noone, Nitin Shivappa, Simo Du
Publikováno v:
Diabetes. 70
Background: This study presents real-world effectiveness of sema OW in a cohort of US commercially insured/Medicare Advantage T2D patients newly initiating a GLP-1 agonist. Methods: Claims and lab result data were used to identify T2D patients who in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::120b80d25809808310776b1a1708c5ce
https://doi.org/10.2337/db21-683-p
https://doi.org/10.2337/db21-683-p
Autor:
Yurek M. Paprocki, Nitin Shivappa, Vincent J. Willey, Joshua Noone, Caroline Swift, Hiangkiat Tan, Simo Du
Publikováno v:
Diabetes. 70
Antidiabetic medication (med) treatment patterns often differ based on a variety of patient and prescriber factors. Understanding these patterns may provide insight on optimizing therapy, especially when considering initiation of a new therapy. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7aafb605c336ce5b3f3befc315a0e839
https://doi.org/10.2337/db21-653-p
https://doi.org/10.2337/db21-653-p
Autor:
Caroline Swift, Joshua Noone, Nitin Shivappa, Simo Du, Yurek M. Paprocki, Vincent J. Willey, Hiangkiat Tan
Publikováno v:
Diabetes. 70
Background: Both primary care physicians (PCPs) and endocrinologists (Endos) commonly prescribe T2D medications. This study presents real-world effectiveness of sema OW by prescriber specialty in a cohort of US commercially insured/Medicare Advantage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba782cd79c72f78de29b654845a5b7c6
https://doi.org/10.2337/db21-1271-pub
https://doi.org/10.2337/db21-1271-pub
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Diabetes. 69
Background: This study presents real-world evidence on effectiveness of sema OW in a large cohort of T2D patients. Methods: Claims and lab result data were used to identify T2D patients who initiated sema OW between 2/1/18 - 4/30/19 (index as first c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63ec4fef067475e8485d9e6fcb56a1a3
https://doi.org/10.2337/db20-953-p
https://doi.org/10.2337/db20-953-p